ArticleAPL bioengineering2025
Prediction of chronic obstructive pulmonary disease based on multimodal data and deep learning.
Article in APL bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the issues of insufficient utilization of multimodal information, modal heterogeneity, and data gaps leading to poor model generalization in early prediction of chronic obstructive pulmonary disease (COPD), a deep learning-based multimodal dynamic fusion network (MMDF-Net) is proposed. This model integrates chest CT images, pulmonary function indicators, and environmental exposure data. It aligns image and non-image features via a dual-tower cross-modal contrastive learning module, mitigating semantic differences across modalities. A conditional generative adversarial network is used to generate high-fidelity environmental exposure data, reducing reliance on data completeness. A dynamic gating fusion mechanism adaptively adjusts multimodal weights based on patient smoking history, age, and other attributes to suppress noise. On the COPD Gene dataset, MMDF-Net achieves an area under the curve (AUC) of 0.92, a sensitivity of 92.3%, and a specificity of 88.7%, significantly outperforming single-modal models and dynamically adjusting weights according to disease stage. These results demonstrate that this multimodal dynamic fusion strategy can effectively address data heterogeneity and individual differences, providing technical support for precise early intervention in COPD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.